CCI clears Seventy Second Investment stake acquisition in Manipal Health Enterprises Ruchika Sharma16 Jan 2024 12:30 PM ISTNew Delhi: Fair trade regulator Competition Commission of India (CCI) has cleared Seventy Second Investment Company's proposed stake acquisition...
University of Oxford scientists launch first human vaccine trials for deadly Nipah virus Ruchika Sharma16 Jan 2024 11:43 AM ISTUK: Scientists at the University of Oxford in the UK have launched first-in-human vaccine trials for the deadly Nipah virus which impacts many...
ICMR-National Institute Of Malaria Research Gets CDSCO Panel Nod To Study Curcumin Dr. Divya Colin15 Jan 2024 5:45 PM ISTNew Delhi: In a significant development, the ICMR (Indian Council of Medical Research)- the National Institute of Malaria Research has got approval...
Union Budget 2024: Pharma industry seeks fiscal incentives for RnD Ruchika Sharma15 Jan 2024 1:30 PM ISTNew Delhi: The pharma industry has sought fiscal incentives to promote research and development (R&D) in the sector, as it is likely to reach...
Yet to take decision on roll-out of HPV vaccination against cervical cancer: Govt Ruchika Sharma15 Jan 2024 12:30 PM ISTNew Delhi: The Union Health Ministry has said it has yet to take a decision on the roll-out of HPV vaccination against cervical cancer in the country....
Lupin bags USFDA nod for hypertension drug Propranolol Hydrochloride ER Ruchika Sharma15 Jan 2024 11:48 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (U.S....
EU regulator starts safety review of CAR-T cancer cell therapies Ruchika Sharma15 Jan 2024 9:00 AM ISTThe European Union's drug watchdog has said it had started a review into the safety risks associated with cancer cell therapies made by companies such...
Alembic Pharma Gets CDSCO Panel Nod to Study FDC Carbidopa, Levodopa ER Capsule for export purpose only Dr. Divya Colin14 Jan 2024 5:45 PM ISTNew Delhi: The drug major Alembic Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Recombinant L-Asparginase not approved in India, conduct CT to study: CDSCO Panel tells Gennova Biopharmaceutical Dr. Divya Colin14 Jan 2024 5:00 PM ISTNew Delhi: Highlighting that recombinant L-Asparginase is presently not approved in India, the Subject Expert Committee (SEC) functional under the...
AbbVie unveils Produodopa for Advanced Parkinson's Disease in EU Ruchika Sharma14 Jan 2024 1:00 PM ISTNorth Chicago, III.: AbbVie has announced the launch of PRODUODOPA (foslevodopa/foscarbidopa) in the European Union for the treatment of advanced...
Bayer's AskBio begins Phase II GenePHIT trial in Congestive Heart Failure Ruchika Sharma14 Jan 2024 11:30 AM ISTBerlin: Bayer AG and Asklepios BioPharmaceutical, Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer...
Boehringer expands production site in Greece for new medicine Ruchika Sharma14 Jan 2024 9:00 AM ISTIngelheim: Boehringer Ingelheim, a research-driven biopharmaceutical company, has announced a further expansion and upgrade of its plant in...
